Bridgewater Associates’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,931
Closed -$187K 717
2024
Q3
$187K Sell
13,931
-15,785
-53% -$233K ﹤0.01% 769
2024
Q2
$411K Sell
29,716
-4,995
-14% -$79.1K ﹤0.01% 774
2024
Q1
$650K Sell
34,711
-12,882
-27% -$258K ﹤0.01% 604
2023
Q4
$1.08M Sell
47,593
-621
-1% -$13.5K 0.01% 629
2023
Q3
$1.2M Buy
48,214
+4,972
+11% +$125K 0.01% 585
2023
Q2
$1.21M Sell
43,242
-6,543
-13% -$162K 0.01% 551
2023
Q1
$1.11M Buy
49,785
+8,367
+20% +$219K 0.01% 550
2022
Q4
$1.1M Sell
41,418
-15,290
-27% -$499K 0.01% 633
2022
Q3
$1.61M Buy
56,708
+745
+1% +$19.2K 0.01% 604
2022
Q2
$1.17M Buy
55,963
+6,371
+13% +$119K ﹤0.01% 777
2022
Q1
$1.07M Buy
49,592
+20,617
+71% +$447K ﹤0.01% 794
2021
Q4
$804K Buy
+28,975
New +$702K ﹤0.01% 610

Other funds holding CCRN

Bridgewater Associates's CCRN Position: Q4 2024 in Review

Bridgewater Associates sold out of Cross Country Healthcare (CCRN) in Q4 2024, closing a stake of 13,931 shares — an estimated $187K sold.

Bridgewater Associates first reported a position in CCRN in Q4 2021 and held it in 12 quarters. The position peaked at $1.61M in Q3 2022. 175 funds tracked by Wall St. Rank hold CCRN as of Q4 2024.

  • Bridgewater Associates reported no remaining Cross Country Healthcare position as of Q4 2024 after selling out during the quarter.
  • Bridgewater Associates sold 13,931 Cross Country Healthcare shares in Q4 2024, an estimated $187K.
  • Bridgewater Associates first reported a position in Cross Country Healthcare in Q4 2021 and held it in 12 quarters.
  • Bridgewater Associates's Cross Country Healthcare position peaked at $1.61M in Q3 2022.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2024.

Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.